In breast cancer, the GABA‐A receptor pi subunit (GABRP) promotes cellular proliferation and differentiation through the activation of the ERK1/2 signaling pathway, enhancing the invasive potential of tumor cells [371]. Here, GABRP is linked to breast carcinoma.